domingo, 20 de abril de 2025

Oral vaccine for norovirus shows promise in Phase 1b trial Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.

https://www.drugdiscoverynews.com/oral-vaccine-for-norovirus-shows-promise-in-phase-1b-trial-16318?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-8oRpvAORsA4u_-yrAMK5oHzleh84Nz0HGeIwWiDBksfXuz6uC1BvMMir6mQOjPtJfAlAz-jOZ68LCoHaw_bljPcFb_YQ&_hsmi=357289123&utm_content=357289123&utm_source=hs_email

No hay comentarios:

Publicar un comentario